North America Stem Cell Therapy Market Trends, Growth, Size, Share, Segmentation and Forecast to 2028

 


The North America stem cell therapy market was valued at US$ 1,299.39 million in 2022 and is projected to reach US$ 3,582.26 million by 2028; it is expected to grow at a CAGR of 18.4% from 2022 to 2028. 

Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management is Driving the North America Stem Cell Therapy Market

Stem cell therapy has been widely investigated across the world. Stem cells are mainly used to replace dying cells and reconstruct damaged tissues. Based on the results of extensive stem cell research conducted so far, many scientists have claimed that these cells could probably be utilized to generate cures and treatments for diseases such as cancer and cardiovascular disease. Newly developed stem cell therapies involve replacing disease-causing cells with stem cells. Many potential treatments involving stem cells are in different phases of clinical trials. The FDA has also approved a few stem cell therapies involved in treating complications related to stem cell transplants. In September 2021, the US Food and Drug Administration (FDA) announced approval for "Ruxolitinib" for treating "graft-versus-host-disease" (GVHD) in patients aged 12 and above. Ruxolitinib provides a patient new hope that suffers from fatal complications associated with stem cell transplants.

📚𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲@ https://www.businessmarketinsights.com/sample/BMIRE00028486

Researchers are further investigating the use of stem cell therapy in treating autoimmune disorders. For example, stem cells can turn into the cells of damaged organs and are used in treating autoimmune diseases. Treatment is carried out using mesenchymal stem cells or fetal stem cells. Hematopoietic stem cells are currently used for treating more than 80 medicals conditions, including immune system diseases, blood disorders, neurological disorders, metabolic disorders, genetic disorders, and cancer types such as leukemia and lymphoma.

𝐓𝐡𝐞 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 MEDIPOST

RichSource

BioTime, Inc.

Mesoblast Limited

U.S. Stem Cell, Inc.

TiGenix NV

AlloSource

NuVasive Inc

📚𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐋𝐢𝐧𝐤 @ https://www.businessmarketinsights.com/reports/north-america-stem-cell-therapy-market

·         Segments Covered

 

By Type

  • Adult Stem Cell Therapy
  • Embryonic Stem Cell Therapy
  • Induced Pluripotent Stem Cell Therapy
  • Other Stem Cell Therapy

By Treatment

  • Allogeneic
  • Autologous

By Application

  • Musculoskeletal
  • Dermatology
  • Cardiology
  • Drug Discovery & Development
  • Other Applications

By End User

  • Hospitals & Specialty Clinics
  • Academic & Research Institutes

Canada: Growth Through Investment and Healthcare Development:

The Canadian stem cell therapy market is experiencing steady growth, driven by:

  • Healthcare System Development: Ongoing development and modernization of the Canadian healthcare system are creating a favorable environment for the adoption of advanced therapies like stem cell therapy.
  • Increased Investment: Rapidly increasing investments in stem cell therapy technology, both from public and private sources, are fueling research and development.
  • Government Support: The Canadian government has shown support for stem cell research, through funding and regulatory pathways.
  • Strong Research Institutions: Canadian universities and research hospitals are performing cutting edge stem cell research.

Mexico: Emerging Opportunities and Growing Awareness:

The Mexican stem cell therapy market is poised for significant growth, driven by:

  • Increasing Awareness: A growing awareness of the benefits offered by stem cell therapy among the Mexican population is driving demand.
  • Rising Healthcare Expenditure: Increasing healthcare expenditure in Mexico is creating opportunities for the adoption of advanced therapies.
  • Medical Tourism: Mexico's growing medical tourism industry, particularly in areas like regenerative medicine, is attracting patients seeking stem cell therapies.
  • Developing Healthcare Infrastructure: While still developing, Mexico's healthcare infrastructure is improving, allowing for greater access to advanced treatments.

Overall Market Drivers:

Across all three countries, several common factors are driving the North American stem cell therapy market:

  • Rising Prevalence of Chronic Diseases: The increasing prevalence of chronic diseases, such as cardiovascular disease, diabetes, and neurological disorders, is creating a growing need for effective therapies.
  • Aging Population: The aging population in North America is driving demand for regenerative medicine therapies to address age-related conditions.
  • Technological Advancements: Continuous advancements in stem cell technology, including cell culture, gene editing, and delivery systems, are expanding the therapeutic potential of stem cells.
  • Clinical Trial Activity: An increasing number of clinical trials evaluating the safety and efficacy of stem cell therapies are generating positive data and driving market growth.

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

Comments

Post a Comment

Popular posts from this blog

Europe Power Management IC Market- Global Drivers, Opportunities, Trends, and Forecasts to 2028

Image
The power management IC market in Europe is expected to grow from US$ 11,342.18 million in 2021 to US$ 17,503.59 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028. The adoption of electric vehicles is growing tremendously across the region. Sales of electric vehicles (EVs) have increased in the Europe markets. The Power management plays a significant role with respect to the efficiency of the device, be it an ultra-low-power wireless sensor network or automotive high-voltage power converter. With a rise in requirement for proper power management, companies are looking at manufacturing customized power management integrated chips. The stringent emission norms in European countries are driving the demand for electric vehicles to a notable extent. Thus, respective policies, norms, incentives, and subsidies promote the sales of electric vehicles across the region. A PMIC is widely used in various automotive applications, such as ADAS, infotainment, battery mana...
Read more

Europe Automated Waste Collection Systems Market Size, Share, Trends, Segmentation And Forecast To 2028

Europe automated waste collection systems market in Europe is expected to grow from US$ 103.11 million in 2021 to US$ 150.18 million by 2028; it is estimated to grow at a CAGR of 5.5% from 2021 to 2028. Waste collection is an important aspect of waste management, but rates differ a lot based on income levels, with upper-middle- and high-income countries having almost universal waste collection. Different types of waste produced in the world include food waste, glass and green, paper and cardboard, rubber and leather, wood, plastic, and so on. Thus, the rising global waste production is influencing the adoption of technologically advanced solutions such as automatic waste collection systems to collect the waste and manage it for ensuring safety and environmental hygiene of the population. 📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲@ https://www.businessmarketinsights.com/sample/TIPRE00027445 The European region comprise of significant number of automated waste collection ...
Read more

Europe Airway Management Devices Market Size, Share, Challenges, Trend, Segmentation and Forecast to 2028

Image
  The airway management devices market in Europe is expected to grow from US$ 508.81 million in 2022 to US$ 762.14 million by 2028. It is estimated to grow at a CAGR of 7.0% from 2022 to 2028. Rising Prevalence of Respiratory Disorders Europe Airway Management Devices Market Chronic respiratory diseases are among the most prevalent noncommunicable diseases worldwide due to the increase in the noxious environment and occupational and behavioral inhalation. This spectrum of diseases includes chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease, pulmonary sarcoidosis, and pneumoconiosis (such as silicosis and asbestosis). According to the World Health Organization (WHO), COPD is the third leading cause of death. The National Health Service states that ~1.17 million people in the UK were diagnosed with COPD in 2021, i.e., ~1.9% of the total population. The rising prevalence of respiratory disorders is driving the demand for airway management devices. Europe A...
Read more